Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Exp Toxicol Pathol ; 68(4): 223-31, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26775023

RESUMO

Atrazine (ATR) is primarily distributed in liver and hazardous to animal health. Cytochrome P450 enzyme system (CYP450s) is responsible for the biotransformation of toxic substances. Lycopene (LYC) prevents the herbicide-induced toxicity. However, it is unclear that LYC protects against ATR-induced hepatotoxicity via modifying CYP450s. To ascertain the chemoprevention of LYC on ATR-induced hepatotoxicity, male Kunming mice were treated with LYC (5mg/kg) and/or ATR (50mg/kg or 200mg/kg) by gavage administration for 21 days. These results showed that ATR induced the increase of total CYP450 and Cytochrome b5 (Cyt b5) contents and stimulated the activities of CYP450s enzymes (erythromycin N-demethylase (ERND), aminopyrin N-demethylase (APND), aniline-4-hydeoxylase (AH) and NADPH-cytochrome c reductase (NCR)) in hepatic microsomes. The mRNA expressions of six CYP450s genes (increase: CYP1a1, CYP2a4, CYP3a57 and decrease: CYP2f2, CYP3a11, CYP4a31) were significantly influenced by ATR. LYC modulated the contents and activities of CYP450s and normalized the expressions of four CYP450s genes (CYP1b1, CYP2a4, CYP2e1, and 4A14). These findings suggested that ATR induced hepatic CYP450s disturbance and influenced the gene expression of CYP450s. Lycopene protected against hepatic CYP450s disturbance induced by ATR via modifying the hepatic CYP450s activities and transcription in mice.


Assuntos
Antioxidantes/uso terapêutico , Atrazina/toxicidade , Carotenoides/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Sistema Enzimático do Citocromo P-450/metabolismo , Poluentes Ambientais/toxicidade , Microssomos Hepáticos/efeitos dos fármacos , Animais , Antioxidantes/administração & dosagem , Biomarcadores/metabolismo , Carotenoides/administração & dosagem , Doença Hepática Induzida por Substâncias e Drogas/enzimologia , Relação Dose-Resposta a Droga , Licopeno , Masculino , Camundongos Endogâmicos , Microssomos Hepáticos/enzimologia , Reação em Cadeia da Polimerase em Tempo Real
2.
Environ Pollut ; 207: 299-307, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26432752

RESUMO

There has been a gradual increase in production and consumption of atrazine (ATR) in agriculture to meet the population rising demands. Female reproduction is necessary for growth and maintenance of population. However, ATR impact on females and particularly ovarian developmental toxicity is less clear. The aim of this study was to define the pathways by which ATR exerted toxic effects on ovarian development of ovary and hypothalamo-pituitary-ovarian (HPO) axis. Female quails were dosed by oral gavage from sexual immaturity to maturity with 0, 50, 250 and 500 mg ATR/kg/d for 45 days. ATR had no effect on mortality but depressed feed intake and growth and influenced the biochemical parameters. Notably, the arrested development of ovaries and oviducts were observed in ATR-exposed quails. The circulating concentrations of E2, P, LH and PRL were unregulated and FSH and T was downregulated in ATR-treated quails. The mRNA expression of GnRH in hypothalamo and LH in pituitary and FSH in ovary was downregulated significantly by ATR exposure and FSH and PRL in pituitary were upregulated. ATR exposure upregulated the level of P450scc, P450arom, 3ß-HSD and 17ß-HSD in ovary and downregulated ERß expression in female quails. However, ATR did not change ERα expression in ovary. This study provides new insights regarding female productive toxicology of ATR exposure. Ovary and oviduct in sexually maturing females were target organs of ATR-induced developmental toxicity. We propose that ATR-induced developmental abnormality of ovary and oviduct is associated with disruption of gonadal hormone balance and HPO axis in female quails.


Assuntos
Atrazina/toxicidade , Coturnix/crescimento & desenvolvimento , Ovário/efeitos dos fármacos , Oviductos/efeitos dos fármacos , Animais , Peso Corporal , Feminino , Hormônios Gonadais , Hormônio Liberador de Gonadotropina/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Ovário/crescimento & desenvolvimento , Oviductos/crescimento & desenvolvimento , Hipófise/efeitos dos fármacos , Reprodução/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...